Pulmonx Corporation (LUNG)

Pulmonx Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	72.99	68.68	53.66	48.42	32.73	32.6
Revenue Growth (YoY)	27.14%	27.98%	10.84%	47.91%	0.42%	62.94%
Cost of Revenue	18.75	17.92	13.8	12.79	11.53	10.18
Gross Profit	54.24	50.75	39.87	35.63	21.2	22.41
Selling, General & Admin	96.28	94.61	83.11	69.87	46.07	34.2
Research & Development	18.04	18.08	15.4	13.06	7.46	6.05
Operating Expenses	114.31	112.69	98.5	82.93	53.53	40.25
Operating Income	-60.07	-61.94	-58.64	-47.3	-32.33	-17.84
Interest Expense / Income	3.55	3.23	1.07	0.83	3.18	2.32
Other Expense / Income	-5.52	-4.9	-1.13	0.19	-3.5	0.19
Pretax Income	-58.1	-60.27	-58.57	-48.32	-32.02	-20.34
Income Tax	0.63	0.57	0.35	0.34	0.21	0.36
Net Income	-58.73	-60.84	-58.92	-48.66	-32.23	-20.7
Shares Outstanding (Basic)	39	38	37	36	10	2
Shares Outstanding (Diluted)	39	38	37	36	10	2
Shares Change	2.83%	2.37%	2.68%	254.74%	473.44%	6.05%
EPS (Basic)	-1.54	-1.60	-1.59	-1.35	-3.16	-11.66
EPS (Diluted)	-1.54	-1.60	-1.59	-1.35	-3.16	-11.66
Free Cash Flow	-37.96	-38.42	-46.4	-45.06	-31.54	-21.49
Free Cash Flow Per Share	-0.98	-1.01	-1.25	-1.25	-3.10	-12.10
Gross Margin	74.31%	73.90%	74.29%	73.59%	64.77%	68.77%
Operating Margin	-82.29%	-90.19%	-109.27%	-97.70%	-98.77%	-54.73%
Profit Margin	-80.46%	-88.60%	-109.80%	-100.51%	-98.47%	-63.52%
Free Cash Flow Margin	-52.00%	-55.94%	-86.47%	-93.07%	-96.37%	-65.92%
EBITDA	-50.29	-52.81	-53.49	-44.26	-26.89	-16.82
EBITDA Margin	-68.89%	-76.89%	-99.69%	-91.42%	-82.14%	-51.61%
Depreciation & Amortization	4.27	4.23	4.01	3.23	1.95	1.2
EBIT	-54.55	-57.04	-57.5	-47.49	-28.84	-18.02
EBIT Margin	-74.74%	-83.06%	-107.16%	-98.09%	-88.10%	-55.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).